A non-polyene antifungal antibiotic from Streptomyces albidoflavus PU 23

Journal of Biosciences

Volumn 30, Issue 2, 2005, Pages 201-211

  Augustine, S K ^a   Bhavsar, S P ^b   Kapadnis, B P ^b  

^a Abeda Inamdar Senior College   (India)

^b UNIVERSITY OF PUNE   (India)

Author keywords

Antibiotic; Antifungal; Non polyene; Streptomyces albidoflavus

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; DETERGENT; ERGOSTEROL; HAMYCIN; LYSOZYME; NON POLYENE ANTIFUNGAL ANTIBIOTIC; NYSTATIN; PROTEINASE K; SOLVENT; TRIACYLGLYCEROL LIPASE; TRYPSIN; UNCLASSIFIED DRUG;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; FUNGAL DISEASE;

ACTINOMYCES; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STORAGE; DRUG STRUCTURE; FOURIER TRANSFORMATION; INFRARED SPECTROSCOPY; LIQUID CHROMATOGRAPHY; MELTING POINT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PH; SHELF LIFE; STREPTOMYCES ALBIDOFLAVUS; STRUCTURE ANALYSIS; THERMOSTABILITY; ULTRAVIOLET SPECTROPHOTOMETRY;

ASPERGILLUS; STREPTOMYCES ALBIDOFLAVUS;

EID: 17844375637     PISSN: 02505991     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02703700     Document Type: Article

References (27)

1. Anderson A S and Wellington E M H 2001 The taxonomy of Streptomyces and related genera; Int. J. Syst. Evol. Microbiol. 51 797-814
2. Augustine S K 2004 Bioactive compounds from actinomycetes with a potential to inhibit pathogenic fungi, Ph. D. Thesis, University of Pune, Pune
3. Augustine S K, Bhavsar S P, Baserisalehi M and Kapadnis B P 2004 Isolation, characterization and optimization of antifungal activity of an actinomycete of soil origin; Indian J. Exp. Biol. 42 928-932
4. Barry A L 1980 Procedure for testing antibiotics in agar media: Theoretical considerations; in Antibiotics in laboratory medicine (ed.) V Lorian (Baltimore: Williams and Wilkins) pp 1-23
5. Beck-Sague C M and Jarvis W R 1993 Secular trends in the Epidemiology of nosocomial fungal infections in the United States 1980-1990; J. Infect. Dis. 167 1247-1251
6. Bevan P, Ryder H and Shaw I 1995 Identifying small-molecule lead compounds: The screening approach to drug discovery; Trends Biotechnol. 113 115-121
7. Cappuccino J G and Sherman N 1999 Microbiology - A laboratory manual (Harlow: Benjamin) pp 263-264
8. Collins C H, Lyne P M and Grange J M 1995 Microbiological methods (London: Butterworth and Heinnemann) pp 155-168
9. Cragg G M, Newman D J and Snader K M 1997 Natural product: in drug discovery and development; J. Nat. Prod. 60 52-60
10. Dasgupta F 1998 Antifungal agents - past, present and future possibilities; in Antifungal agents past, present, future prospect (eds) R S Varma, I K Khan and A P Singh (Lucknow: Academy of Chemistry and Biology) pp 29-54
11. Franco M M C and Countinho L E L 1991 Detection of novel secondary metabolites; Crit. Rev. Biotechnol. 11 193-276
12. Georgopapadakou N H and Tkacz J S 1994 Human mycoses: Drugs and targets for emerging pathogens; Science 264 371-373
13. Georgopapadakou N H and Tkacz J S 1996 Antifungal agents: chemotherapeutic targets and immunogenic strategies; Antimicrob. Agents Chemother. 40 279-291
14. Glazer A N and Nikaido H 1995 Antibiotics; in Microbial biotechnology (New York: W H Freeman) pp 431-451
15. Gupte M, Kulkarni P and Ganguli B N 2002 Antifungal Antibiotics; Appl. Microbiol. Biotechnol. 58 46-57
16. Hammer K A, Carson C F and Riley T V 2002 In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi; J. Antimicrob. Chemother. 50 195-199
17. Igraham J L and Igraham C A 2000 Pharmacology; in Introduction to microbiology Second edition (Singapore; Thomson Asia) pp 532-561
18. Lavermicocca P, Valerio F and Visconti A 2003 Antifungal activity of phenyl lactic acid against molds isolated from bakery products; Appl. Environ. Microbiol. 69 634-640
19. Lebbadi M, Galvez A, Maqueda M, Martinez-Bueno M and Valdivia E 1994 Fungicin M-4: a narrow spectrum peptide antibiotic from Bacillus licheniformis M-4; J. Appl. Bacteriol. 78 49-53
20. Motta A S and Brandelli A 2002 Characterization of an antibacterial peptide produced by Brevibacterium linens; J. Appl. Microbiol. 92 63-70
21. Munimbazi C and Bullerman L B 1998 Isolation and partial characterization of antifungal metabolites of Bacillus pumilus; J. Appl. Microbiol. 84 959-968
22. Petrou M A and Shanson D C 2000 Susceptibility of Cryptococcus neoformans by the NCCLS microdilution and E test methods using five defined media; J. Antimicrob. Chemother. 46 815-818
23. Phae C G, Shoda M and Kubota H 1990 Suppressive effect of Bacillus subtilis and its products on phytopathogenic microorganisms; J. Ferment. Bioeng. 69 1-7
24. Prescott M L, Harley J P and Klein D A 2002 Antimicrobial chemotherapy; in Microbiology Fifth edition (New York: McGraw Hill) pp 806-825
25. Shadomy S 1987 Preclinical evaluation of antifungal agents; in Recent trends in the discovery, development and evaluation of antifungal agents (New Jersey: Prous Science) pp 8-14
26. Shadomy S, Espinel-Ingroff A and Cartwright R Y 1985 Laboratory studies with antifungal agents: Susceptibility tests and bioassays; in Manual of clinical microbiology (eds) E H Lenette, A S Balows and W J Hausle (Washington: American Society for Microbiology) pp 991-999
27. Singh R and Garg S R 2003 Detection and characterization of enterocins from Enterococcus sp; Indian J. Exp. Biol. 41 609-613